SEP 07, 2016 1:30 PM PDT

Manipulating the Microbiome to Prevent and Treat Infection

Speaker
  • Professor of Internal Medicine and Pathology, University of Iowa
    Biography
      Dr. Diekema is a Professor of Internal Medicine and Pathology at the University of Iowa Carver College of Medicine. After graduating from Vanderbilt University School of Medicine, Dr. Diekema did an internal medicine residency at the University of Virginia, and completed fellowships in infectious diseases, hospital epidemiology and medical microbiology at the University of Iowa, where he also received an MS in Preventive Medicine.
      Dr. Diekema currently serves as director of the Division of Infectious Diseases at the University of Iowa Carver College of Medicine, associate director of the University of Iowa Hospital Clinical Microbiology Laboratory, the associate hospital epidemiologist at University of Iowa Healthcare.
      Dr. Diekema's clinical and research interests include several aspects of healthcare epidemiology, including the epidemiology of invasive fungal infections in hospitalized patients, and the epidemiology of antimicrobial resistance. He has served on national committees that establish standards in clinical microbiology and infection prevention, including the Clinical and Laboratory Standards Institute (CLSI) and the CDC's Healthcare Infection Control Practices Advisory Committee (HICPAC), of which he is currently co-chair. He is also the immediate past-president of the Society for Healthcare Epidemiology of America (SHEA).

    Abstract

    Healthcare associated infections can be a consequence of a microbiome alteration. Increasingly, treatment and prevention strategies focus on manipulating host microbiota, the two most common examples being (1) suppression of certain skin and mucosal microbiota, and (2) preservation or restoration of intestinal microbial communities.

    After this presentation, participants should be able to:  

    (a) discuss the evidence in support of chlorhexidine application to the skin and oropharynx of hospitalized patients to prevent infection
    (b) implement interventions to reduce the likelihood of Clostridium difficile recurrence after host exposure to antimicrobial agents.
     


    Show Resources
    You May Also Like
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
    MAR 16, 2021 10:00 AM PDT
    C.E. CREDITS
    MAR 16, 2021 10:00 AM PDT
    Date: March 16, 2021 Time: 10:00am (PST) Scientific progress and breakthroughs today are often too expensive for most institutions to acquire. Each year, the National Institutes of Health (N...
    APR 01, 2021 8:00 AM PDT
    C.E. CREDITS
    APR 01, 2021 8:00 AM PDT
    Date: April 01, 2021 Time: 8:00am (PST), 11:00am (EST) Generating therapeutic antibodies is far more challenging than obtaining antibodies that merely recognize their targets. Engineering po...
    DEC 02, 2020 8:00 AM PST
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    SEP 07, 2016 1:30 PM PDT

    Manipulating the Microbiome to Prevent and Treat Infection


    Specialty

    Cancer

    Health

    Research And Development

    Brain Diseases

    Bacteria

    Earth Science

    University

    Clinical Medicine

    Disease

    Research

    Cancer Cell

    Vaccine Research

    Geography

    North America50%

    Asia50%

    Registration Source

    Website Visitors100%

    Job Title

    Student50%

    Medical Laboratory Technician50%

    Organization

    Academic Institution50%

    Manufacturer - Other50%


    Show Resources
    Loading Comments...
    Show Resources
    Attendees
    • See more